GABRIEL GREENE: Open Payments
NPI 1568114734 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,659 in 73 payments from 18 companies in 2025. Trend: 2023 $775 · 2024 $932 · 2025 $1,659
Food & beverage: $1,642Education: $17
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. | 14 | $284 |
| AstraZeneca Pharmaceuticals LP | 11 | $222 |
| Axsome Therapeutics, Inc. | 9 | $185 |
| Avadel CNS Pharmaceuticals, LLC | 6 | $153 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $139 |
| GENZYME CORPORATION | 5 | $101 |
| Grifols USA, LLC | 4 | $91 |
| Regeneron Healthcare Solutions, Inc. | 4 | $83 |
| GlaxoSmithKline, LLC. | 4 | $74 |
| Mallinckrodt Hospital Products Inc. | 3 | $74 |
Products named: Arikayce, Sunosi, FASENRA, DUPIXENT, LUMRYZ, OFEV, Prolastin-C Liquid, NUCALA.
Industry payments across LA — which companies pay providers there.
